002901 大博医疗
2024/03 - 三个月
人民幣(K¥)
与去年同期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)
营业总收入427,2809.17%1,533,1211,434,0991,994,3341,586,860
减:营业总成本368,53711.60%1,459,1731,369,8421,244,770925,534
    其中:营业成本136,13914.81%492,239333,920311,056224,231
               财务费用(769)-89.73%(23,186)(25,228)(7,816)(13,523)
               资产减值损失(4,977)-31.52%(50,141)(12,055)(8,976)(6,420)
公允价值变动收益(1,428)19.73%5,6021,7711,2182,520
投资收益4,19923.33%9,74716,20620,1894,812
    其中:对联营企业和合营企业的投资收益------(120)163
营业利润76,55516.04%103,236147,452822,007714,740
利润总额75,99615.26%99,741147,459802,512709,633
减:所得税费用8,795175.49%13,40537,892111,01294,879
净利润67,2017.10%86,336109,567691,500614,754
减:非控股权益5,47320.65%27,36417,01218,1919,070
股东净利润61,7296.05%58,97292,555673,309605,684

市场价值指针
每股收益 (元) *0.1507.14%0.1400.2201.6801.510
每股派息 (元) *----0.250--0.5000.800
每股净资产 (元) *7.5321.94%7.3877.246--5.231
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容